Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
doi: 10.1038/s41586-019-1707-0 46 BersukerKHendricksJMLiZMagtanongLFordBTangPHet al
The US Food and Drug Administration recently approved a phase II clinical trial of afamelanotide (SCENESSE, Clinuvel Pharmacueticals Ltd) combined with narrowband UV-B therapy for the treatment of vitiligo.4 We report the case of a 25-year-old man who came to our department for the sudden eruption of multiple melanocytic nevi and rapid transformation of existing nevi
The vial ships with sterile syringes, alcohol swabs, and a printed protocol sheet at no additional cost.
Report any unusual symptoms such as severe joint pain, new or worsening breathlessness, ankle swelling, or visual changes
& Forster, M
US$ 29.59
US$ 28.38
US$ 25.58
US$ 24.68
US$ 25.15
US$ 25.60
US$ 27.03
US$ 22.29
